-
公开(公告)号:US20070179535A1
公开(公告)日:2007-08-02
申请号:US11525204
申请日:2006-09-22
申请人: Anthony Morrissey , Declan Soden , Gerald O'Sullivan , Christopher Collins , Colum Dunne , John Piggott , Denton Prior , Andrew Watson , Peter McGeehin
发明人: Anthony Morrissey , Declan Soden , Gerald O'Sullivan , Christopher Collins , Colum Dunne , John Piggott , Denton Prior , Andrew Watson , Peter McGeehin
CPC分类号: C12M35/02 , A61B18/1477 , A61B18/1492 , A61B2018/0016 , A61B2018/00291 , A61B2018/00482 , A61B2018/00494 , A61B2018/1425 , A61B2018/143 , A61B2218/002 , A61N1/0424 , A61N1/0476 , A61N1/327 , A61N5/0601 , A61N5/062
摘要: Apparatus (20) for carrying out a prophylactic or treatment procedure on tissue comprises a device (21) having a chamber (22) and at least one active element such as an electrode (23) within the chamber (22). The chamber (22) has an opening (26) through which tissue is drawn into the chamber (22). Means for drawing the tissue into the chamber may comprise a vacuum lumen with vacuum orifices (25) in the chamber (22). Treatment such as electroporation may be applied to tissue in the chamber (22).
摘要翻译: 用于在组织上执行预防或治疗过程的装置(20)包括在腔室(22)内具有腔室(22)和至少一个有源元件(例如电极(23))的装置(21)。 腔室(22)具有一个开口(26),组织被吸入腔室(22)中。 用于将组织拉入腔室的装置可以包括在腔室(22)中具有真空孔(25)的真空腔。 诸如电穿孔的治疗可以施加到腔室(22)中的组织。
-
公开(公告)号:US08545497B2
公开(公告)日:2013-10-01
申请号:US11525204
申请日:2006-09-22
申请人: Anthony Morrissey , Declan Soden , Gerald O'Sullivan , Christopher Collins , Colum Dunne , John Piggott , Denton A. M Prior , Andrew Watson , Peter McGeehin
发明人: Anthony Morrissey , Declan Soden , Gerald O'Sullivan , Christopher Collins , Colum Dunne , John Piggott , Denton A. M Prior , Andrew Watson , Peter McGeehin
IPC分类号: A61B18/18
CPC分类号: C12M35/02 , A61B18/1477 , A61B18/1492 , A61B2018/0016 , A61B2018/00291 , A61B2018/00482 , A61B2018/00494 , A61B2018/1425 , A61B2018/143 , A61B2218/002 , A61N1/0424 , A61N1/0476 , A61N1/327 , A61N5/0601 , A61N5/062
摘要: Apparatus (20) for carrying out a prophylactic or treatment procedure on tissue comprises a device (21) having a chamber (22) and at least one active element such as an electrode (23) within the chamber (22). The chamber (22) has an opening (26) through which tissue is drawn into the chamber (22). Means for drawing the tissue into the chamber may comprise a vacuum lumen with vacuum orifices (25) in the chamber (22). Treatment such as electroporation may be applied to tissue in the chamber (22).
摘要翻译: 用于在组织上执行预防或治疗过程的装置(20)包括在腔室(22)内具有腔室(22)和至少一个有源元件(例如电极(23))的装置(21)。 腔室(22)具有一个开口(26),组织被吸入腔室(22)中。 用于将组织拉入腔室的装置可以包括在腔室(22)中具有真空孔(25)的真空腔。 诸如电穿孔的治疗可以施加到腔室(22)中的组织。
-
公开(公告)号:US20100196352A1
公开(公告)日:2010-08-05
申请号:US12451249
申请日:2008-05-02
IPC分类号: A61K39/395 , A61K38/43 , A61K38/28 , A61K38/16 , A61K31/702 , C07K14/00
CPC分类号: A23K50/40 , A23K20/147 , A23K20/163 , A23K50/00 , A23K50/20 , A23K50/70 , A23L33/19 , A23V2002/00 , A23V2200/316 , A23V2250/5062 , A23V2250/54252
摘要: Use of whey protein isolate in the preparation of a composition for increasing mean aerobic capacity, enhanced haemoglobin production, enhanced red blood cell production and increased mean corpuscular haemoglobin concentration in competitive species, such as equine species, involved in strenuous activity. The composition may further comprise a prebiotic such as a fructo-oligosaccharide for example inulin.
摘要翻译: 在制备用于增加平均有氧能力,增强血红蛋白产生,增强的红细胞生成和增加参与剧烈活动的马类竞争物种的平均红细胞血红蛋白浓度的组合物中使用乳清蛋白分离物。 组合物还可以包含益生元,例如果寡糖例如菊粉。
-
公开(公告)号:US20100317734A1
公开(公告)日:2010-12-16
申请号:US12734929
申请日:2008-12-04
申请人: Michael Anthony Folan , Colm O'Brien , Colum Dunne
发明人: Michael Anthony Folan , Colm O'Brien , Colum Dunne
CPC分类号: A61K45/06 , A61K31/19 , A61K35/20 , A61K2300/00
摘要: An antimicrobial composition comprising a blend of two or more natural free fatty acids derivable from milk serum lipid, the free fatty acids being selected from: butyric (C4); caproic (C6); caprylic (C8); capric (C10); lauric (C12); myristic (C14); palmitic (C 16): palmitoleic 5 (C16:1); stearic (C1 8); oleic (C18:1); linoleic (Cl 8:2); linolenic (C18:3); and esterified derivatives thereof, and a milk, protein as an emulsifying agent for the free fatty acids wherein at least 35% of the total lipid content comprises free fatty acids selected from one or more of: butyric, caproic, caprylic, capric and lauric.
摘要翻译: 一种抗微生物组合物,其包含两种或更多种可衍生自乳清脂质的天然游离脂肪酸的混合物,所述游离脂肪酸选自:丁酸(C4); 己酸(C6); 辛酸(C8); capric(C10); 月桂酸(C12); 肉豆蔻酸(C14); 棕榈酸(C16):棕榈油5(C16:1); 硬脂酸(C1 8); 油酸(C18:1); 亚油酸(C18:2); 亚麻酸(C18:3); 和其酯化衍生物,以及乳蛋白作为游离脂肪酸的乳化剂,其中总脂质含量的至少35%包含选自以下中的一种或多种的游离脂肪酸:丁酸,己酸,辛酸,癸酸和月桂酸。
-
5.
公开(公告)号:US20070128252A1
公开(公告)日:2007-06-07
申请号:US11553817
申请日:2006-10-27
申请人: Loren Ward , Eric Bastian , Starla Paulsen , Colum Dunne
发明人: Loren Ward , Eric Bastian , Starla Paulsen , Colum Dunne
摘要: A nutritional supplement composition having a therapeutically effective amount of peptides is provided for the treatment of body weight conditions. The nutritional supplement may also comprise milk minerals, such as calcium and/or be combined with a protein source including κ-casein fragment 106-169. The nutritional supplement composition is administered in amounts effective for limiting weight gain and/or enhancing weight loss, as well as promoting overall good health, in the treatment of body weight conditions, including overweight and obesity. In one embodiment, the supplement is administered through a calorically restricted diet.
摘要翻译: 提供具有治疗有效量的肽的营养补充剂组合物用于治疗体重条件。 营养补充剂还可以包含乳矿物质,例如钙和/或与包括κ-酪蛋白片段106-169的蛋白质来源组合。 营养补充剂组合物以治疗体重状况(包括超重和肥胖)有效地限制体重增加和/或增加体重减轻以及促进整体良好健康的量施用。 在一个实施方案中,补充物通过热量限制的饮食来施用。
-
-
-
-